ACALABRUTINIB WITH RITUXIMAB AS FIRST-LINE THERAPY FOR OLDER PATIENTS WITH MANTLE CELL LYMPHOMA-A PHASE II CLINICAL TRIAL

Authors
Category Primary study
Conference17th International Conference on Malignant Lymphoma
Year 2023
This article has no abstract
Epistemonikos ID: e113172a71eca5dc0167f1828be4db87b4a80482
First added on: May 18, 2026